▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1375 by analyst upside · 2026-09-27
LFCR
Lifecore Biomedical, Inc.
Healthcare · Market Cap $159M · P/E 0x
ANALYST PRICE TARGET
+60.7%
implied upside to consensus target
Current Price $4.2
Consensus Target $6.75
Bull Target $9.0
Bear Target $5.0
Analysts Covering 3
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
1
Hold
1
Sell
0
52-Week Low $3.63
52-Week High $8.98
YTD Return -45.7%
FUNDAMENTALS
Market Cap $159M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.27
PEG Ratio 2.66
Dividend Yield N/A
Revenue (TTM) $129M
Profit Margin -23.8%
52-WEEK RANGE
52-Week Low $3.63
52-Week High $8.98
Current Price $4.2
Bear Target $5.0
Bull Target $9.0
● Now $4.2 ● Target $6.75
TRADING DATA
Avg Volume 154K
YTD Return -45.7%
Analyst Count 3
Consensus Buy
Upside to Target +60.7%
Last Updated 2026-09-27

ANALYST SUMMARY

Lifecore Biomedical, Inc. (LFCR) is currently trading at $4.2 with a Wall Street consensus price target of $6.75, implying potential upside of 60.7% over the next 12 months. 3 analysts currently cover LFCR, with a consensus rating of Buy - 67% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $9.0, while the most cautious has a target of $5.0.

LFCR operates in the Healthcare sector with a market capitalisation of $159M. The stock is down 45.7% year-to-date and is currently trading near the lower end of its 52-week range of $3.63 – $8.98.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

OPRX +54.2%
OptimizeRx Corporation
$151M · P/E 32.2x · Buy
CGEN +93.3%
Compugen Ltd.
$225M · P/E 6.3x · Buy
INFU +32.4%
InfuSystem Holdings, Inc.
$253M · P/E 31.8x · Buy
VMD +40.3%
Viemed Healthcare, Inc.
$339M · P/E 24.7x · Buy
CYH +7.4%
Community Health Systems, Inc.
$415M · P/E 1.7x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for LFCR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barrington Research - Reiterated
Outperform → Outperform 2026-06-16 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-04-29 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-03-27 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-03-24 Building track record
Barrington Research ↑ Upgrade
Market Perform → Outperform 2026-03-17 Building track record
Keybanc ● Initiated
Sector Weight 2025-09-04 Building track record
William Blair ● Initiated
Outperform 2025-05-21 44% win rate (9 calls)
Stephens & Co. reit
Equal-Weight → Equal-Weight 2025-01-03 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
36
out of 100
Coverage depth
11/30
Consensus clarity
11/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →